Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

Dendritic cells (DCs) are antigen-presenting cells (APCs) that are essential for the activation of immune responses. In various malignancies, these immunostimulatory properties are exploited by DC-therapy, aiming at the induction of effective anti-tumor immunity by vaccination with ex vivo antigen-l...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts, Heleen Vroman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-12-01
Subjects:	DC-therapy combination therapy chemotherapy radiotherapy immune checkpoint inhibitors
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2018.02759/full

Similar Items

Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review
by: Jiamin Xu, et al.
Published: (2024-07-01)

Radiotherapy and immunotherapy
by: Ewa Sierko
Published: (2023-02-01)

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
by: Sjoerd H van der Burg, et al.
Published: (2020-10-01)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
by: Clare Y. Slaney, et al.
Published: (2023-01-01)

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
by: Yani Berckmans, et al.
Published: (2023-09-01)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
by: Luca Cantini, et al.
Published: (2020-03-01)

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response
by: Floris Dammeijer, et al.
Published: (2021-02-01)

Current Status and Prospects of Fertility Preservation Strategies for Patients with Tumors
by: Changyue YAO, et al.
Published: (2024-12-01)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
by: Greeshma Rajeev-Kumar, et al.
Published: (2023-02-01)

Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
by: Alexander H. Shannon, et al.
Published: (2023-07-01)

New insight in immunotherapy and combine therapy in colorectal cancer
by: Kai Ji, et al.
Published: (2025-01-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
by: Salima Shebbo, et al.
Published: (2024-03-01)

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
by: Lin Zhang, et al.
Published: (2022-08-01)

In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
by: Luciano Castiello, et al.
Published: (2019-09-01)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
by: Yiyi Yan, et al.
Published: (2018-07-01)

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
by: Paolo A. Ascierto, et al.
Published: (2023-07-01)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01)

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
by: Rui Xing, et al.
Published: (2021-11-01)

Progress in immunotherapy for brain metastatic melanoma
by: Shicheng Zheng, et al.
Published: (2025-01-01)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
by: Yanyang Nan, et al.
Published: (2023-08-01)

Biomarkers and immunotherapy in endometrial cancer: mechanisms and clinical applications
by: Lianfang Zhao, et al.
Published: (2025-10-01)

Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer
by: Lama Abujamous, et al.
Published: (2024-03-01)

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases
by: Kelly H. Yoo, et al.
Published: (2023-08-01)

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model
by: JiaMin Huang, et al.
Published: (2024-12-01)

Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
by: Lin Zhu, et al.
Published: (2024-06-01)

Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review
by: Yu-Ting Lee, et al.
Published: (2020-12-01)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
by: Yun Hua Lee, et al.
Published: (2020-09-01)

A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
by: Yu Rim Lee
Published: (2023-09-01)

Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
by: Ting Zhang, et al.
Published: (2025-06-01)

Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
by: Hua Lu, et al.
Published: (2025-06-01)

Editorial: Advances in immunotherapy and combination therapy for biliary tract cancers
by: Chengpei Zhu, et al.
Published: (2024-01-01)

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01)

Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
by: Heleen Vroman, et al.
Published: (2017-08-01)

DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY
by: Güneş Esendağlı
Published: (2022-08-01)

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
by: Hao Zhang, et al.
Published: (2023-03-01)

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
by: Reut Hadash-Bengad, et al.
Published: (2020-02-01)

Immunotherapy in breast cancer: current landscape and emerging trends
by: Ran Ran, et al.
Published: (2025-05-01)

Advancements in Cancer Immunotherapies
by: Ruchi Roy, et al.
Published: (2022-12-01)

Salvage surgery after combination immunotherapy for initially unresectable or metastastic hepatocellular carcinoma: A retrospective clinical study
by: Jun-Shuai Xue, et al.
Published: (2023-12-01)